Defects in neurofibromatosis 2 protein function can arise at multiple levels

Human Molecular Genetics

Volumn 7, Issue 3, 1998, Pages 335-345

  Gutmann, David H ^a   Geist, Robert T ^a   Xu, Hua Mei ^a   Kim, Joanna S ^a   Saporito Irwin, Susan ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MERLIN; NERVE PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; GENOTYPE; GROWTH REGULATION; MISSENSE MUTATION; MOUSE; NEUROFIBROMATOSIS; NONHUMAN; NONSENSE MUTATION; PHENOTYPE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ANIMALS; BRAIN; CATTLE; GENES, NEUROFIBROMATOSIS 2; HUMANS; MEMBRANE PROTEINS; MICROTUBULES; MOLECULAR WEIGHT; NEURILEMMOMA; NEUROFIBROMATOSIS 2; NEUROFIBROMIN 2; POINT MUTATION; POLYMERASE CHAIN REACTION; RATS; RECOMBINANT FUSION PROTEINS; TUMOR CELLS, CULTURED;

EID: 0031887651     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/7.3.335     Document Type: Article

References (33)

1. Evans, D.G.R., Huson, S.M., Donnai, D., Neary, W., Blair, V., Newton, V. and Harris, R. (1992) A clinical study of type 2 neurofibromatosis. Q. J. Med., 304, 603-618.
2. Martuza, R.L. and Eldridge, R. (1988) Neurofibromatosis 2 (bilateral acoustic neurofibromatosis). New Engl. J. Med., 318, 685-688.
3. Rouleau, G.A., Merel, P., Lutchman, M., Sanson, M., Zucman, J., Marineau, C., Hoang-Xuan, K., Demczuk, S., Desmaze, C., Plougastel, B., Pulst, S.M., Lenoir, G., Bijisma, E., Fashold, R., Dumanski, J., de Jong, P., Parry, D., Eldridge, R., Aurias, A., Delattre, O. and Thomas, G. (1993) Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature, 363, 515-521.
4. Trofatter, J.A., MacCollin, M.M., Rutter, J.L., Murrell, J.R., Duyao, M.P., Parry, D.M., Eldridge, R., Kley, N., Menon, A.G., Pulaski, K., Haase, V.H., Ambrose, C.M., Munroe, D., Bove, C., Haines, J.L., Martuza, R.L., MacDonald, M.E., Seizinger, B.R., Short, M.P., Buckler, A.J. and Gusella, J.F. (1993) A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell, 72, 1-20.
5. Tsukita, S., Heida, Y. and Tsukita, S. (1989) A new 82 kD barbed end-capping protein (radixin) localized in the cell-to-cell adherens junction: purification and characterization. J. Cell Biol., 108, 2369-2382.
6. Tsukita, S., Oishi, K., Sato, N., Sagara, J., Kawai, A. and Tsukita, S. (1994) ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons. J. Cell Biol., 126, 391-401.
7. Lankes, W.T. and Furthmayr, H. (1991) Moesin: a member of the protein 4.1-talin-ezrin family of proteins. Proc. Natl Acad. Sci. USA, 88, 8297-8301.
8. Gould, K.L., Bretscher, A., Esch, F.S. and Hunter, T. (1989) cDNA cloning and sequencing of the protein-tyrosine kinase substrate, ezrin, reveals homology to band 4.1. EMBO J., 8, 4133-4142.
9. Lankes, W.T., Schwartz-Albiez, R. and Furthmayr, H. (1993) Cloning and sequencing of porcine moesin and radixin cDNA and identification of highly conserved domains. Biochim. Biophys. Acta, 1216, 479-482.
10. Scherer, S.S. and Gutmann, D.H. (1996) Expression of the neurofibromatosis 2 tumor suppressor gene product, merlin, in Schwann cells. J. Neurosci. Res., 46, 595-605.
11. Gonzalez-Agosti, C., Xu, L., Pinney, D., Beauchamp, R., Hobbs, W., Gusella, J. and Ramesh, V. (1996) The merlin tumor suppressor localizes preferentially in membrane ruffles. Oncogene, 13, 1239-1247.
12. Parry, D.M., MacCollin, M.M., Kaiser-Kupfer, M.I., Pulaski, K., Nicholson, H.S., Bolesta, M., Eldridge, R. and Gusella, J.F. (1996) Germ-line mutations in the neurofibromatosis 2 gene: correlations with disease severity and retinal abnormalities. Am. J. Hum. Genet., 59, 529-539.
13. Ruttledge, M.H., Andermann, A.A., Phelan, CM., Claudio, J.O., Han, F.-y., Chretien, N., Rangaratnam, S., MacCollin, M., Short, P., Parry, D., Michels, V., Riccardi, V.M., Weksberg, R., Kitamura, K., Bradbum, J.M., Hall, B.D., Propping, P. and Rouleau, G.A. (1996) Type of mutation in the neurofibromatosis type 2 gene (NF2) frequently determines severity of disease. Am. J. Hum. Genet., 59, 331-342.
14. MacCollin, M., Braverman, N., Siffert, J., Hofman, K., Gusella, J. and Parry, D. (1995) Identical inactivating mutation in three children with neurofibromatosis type 2. Ann. Neurol., 38, 554-555.
15. Sherman, L., Xu, H.-M., Geist, R.T., Saporito-Irwin, S., Howells, N., Morrison, H., Ponta, H., Herrlich, P. and Gutmann, D.H. (1997) Interdomain binding mediates tumor growth suppression by the NF2 gene product. Oncogene, 15, 2505-2509.
16. Tikoo, A., Varga, M., Ramesh, V., Gusella, J. and Maruta, H. (1994) An anti-ras function of neurofibromatosis type 2 gene product (NF2/merlin). J. Biol. Chem., 269, 23387-23390.
17. Lutchman, M. and Rouleau, G.A. (1995) The neurofibromatosis type 2 gene product, schwannomin, suppresses growth of NIH 3T3 cells. Cancer Res., 55, 2270-2274.
18. Gary, R. and Bretscher, A. (1993) Heterotypic and homotypic associations between ezrin and moesin, two putative membrane-cytoskeletal linking proteins. Proc: Natl Acad. Sci. USA, 90, 10846-10850.
19. Gary, R. and Bretscher, A. (1995) Ezrin self-association involves binding of an N-terminal domain to a normally masked C-terminal domain that includes the F-actin binding site. Mol. Biol. Cell 6, 1061-1075.
20. Magendantz, M., Henry, M.D., Lander, A. and Solomon, F. (1995) Interdomain interactions of radixin in vitro. J. Biol. Chem., 270, 25324-25327.
21. Andreoli, C., Martin, M., Le Borgne, R., Reggio, H. and Mangeat, P. (1994) Ezrin has properties to self-associate at the plasma membrane. J. Cell Sci., 107, 2509-2521.
22. Henry, M.D., Agosti, C.G. and Solomon, F. (1995) Molecular dissection of radixin: distinct and interdependent functions of the amino- and carboxy-terminal domains. J. Cell Biol., 129, 1007-1022.
23. Gutmann, D.H., Giordano, M.J., Fishback, A.S. and Guha, A. (1997) Loss of merlin expression in sporadic meningiomas, ependymomas and schwannomas. Neurology, 49, 267-270.
24. Lee, J.H., Sundaram, V., Stein, D.J., Kinney, S.E., Stacey, D.W. and Golubic, M. (1997) Reduced expression of schwannomin/merlin in human sporadic meningiomas. Neurosurgery, 40, 578-587.
25. Huynh, D.P., Mautner, V., Baser, M.E., Stavrou, D. and Pulst, S.-M. (1997) Immunohistochemical detection of schwannomin and neurofibromin in vestibular schwannomas, ependymomas, and meningiomas. J. Neuropathol. Exp. Neurol., 56, 382-390.
26. Xu, H.M. and Gutmann, D.H. (1998) Merlin differentially associates with the microtubule and actin cytoskeleton. J. Neurosci. Res., 51, 403-415.
27. Borchelt, D.R., Lee, M.K., Slunt, H.S., Guamieri, M., Xu, Z.-S., Wong, P.C., Brown, R.P., Price, D.L., Sisodia, S.S. and Cleveland, D.W. (1994) Superoxide dismutase I with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity. Proc. Natl Acad. Sci. USA, 91, 8292-8296.
28. Scoles, D.R., Huynh, D.P., Coulsell, E.R., Robinson, N.G.G.,Tamanoi, F. and Pulst, S.-M. (1996) The neurofibromatosis 2 gene product schwannomin interacts with beta-II-spectrin. Am. J. Hum. Genet., 59, A5.
29. Takeshima, H., Izawa, I., Lee, P.S.Y., Safdar, N., Levin, V.A. and Saya, H. (1994) Detection of cellular proteins that interact with the NF2 tumor suppressor gene product. Oncogene. 9, 2135-2144.
30. Gutmann, D.H., Boguski, M., Marchuk, D.,Wigler, M., Collins, F.S. and Ballester, R. (1993) Analysis of the neurofibromatosis type 1 (NF1) GAP-related domain by site-directed mutagenesis. Oncogene, 8, 761-769.
31. Birgbauer, E., Dinsmore, J.H., Winckler, B., Lander, A.D. and Solomon, F. (1991) Association of ezrin isoforms with the neuronal cytoskeleton. J. Neurosci. Res., 30, 232-241.
32. Gregory, P.E., Gutmann, D.H., Boguski, M., Mitchell, A.M., Parks, S., Jacks, T., Jove, R. and Collins, F.S. (1993) The neurofibromatosis type 1 gene product, neurofibromin, associates with microtubules. Somat. Cell Mol. Genet., 19, 265-274.
33. Xu, H.-M. and Gutmann, D.H. (1997) Mutations in the GAP-related domain impair the ability of neurofibromin to associate wilh microtubules. Brain Res., 759, 149-152.